Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Medicine, Oncology, Internal medicine, Lung cancer, Immune system, and Chemotherapy.
Atezolizumab plus bevacizumab and chemotherapy in metastatic nonsquamous NSCLC: the randomized double-blind phase 3 IMpower151 trial
Self-Adaptive Magnetic Liquid Metal Microrobots Capable of Crossing Biological Barriers and Wireless Neuromodulation
The MoS2/rGO embed in macro-porous PAN gel as a novel DGT binding phase for the rapid and accurate detection of trace Hg(II)
Promising efficacy of immune checkpoint inhibitor plus chemotherapy for thoracic SMARCA4-deficient undifferentiated tumor
LBA5 Capivasertib (C) + fulvestrant (F) for patients (pts) with aromatase inhibitor (AI)-resistant HR+/HER2– advanced breast cancer (ABC): Phase III CAPItello-291 trial Chinese cohort
Rh-Endostatin Plus Irinotecan/Cisplatin as Second-Line Therapy for Advanced Esophageal Squamous Cell Carcinoma: An Open-Label, Phase II Study
Transcription factor RUNX3 promotes CD8<sup>+</sup> T cell recruitment by CCL3 and CCL20 in lung adenocarcinoma immune microenvironment
LBA29 Individualized starting dose of niraparib in Chinese patients with platinum-sensitive recurrent ovarian cancer (PSROC): A randomized, double-blind, placebo-controlled, phase III trial (NORA)
Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma
Therapeutic cancer vaccines: From initial findings to prospects